Hedegaard H, Miniño A, Spencer M, Warner M. Drug overdose deaths in the United States, 1999–2020. NCHS Data Brief, no 428. National Center for Health Statistics. 2021.

Gladden RM, O’Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 states, July-December 2017 to January-June 2018. MMWR Morb Mortal Wkly Rep. 2019;68(34):737–44.

Article  PubMed  PubMed Central  Google Scholar 

Friedman J, Shover CL. Charting the fourth wave: geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021. Addiction. 2023;118(12):2477–85.

Article  PubMed  Google Scholar 

Burns M, Tang L, Chang C-CH, et al. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study. Addiction. 2022;117(12):3079–88.

Article  PubMed  PubMed Central  Google Scholar 

Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality. Ann Intern Med. 2018/08/07 2018;169(3):137–145.

Chhatwal J, Mueller PP, Chen Q, et al. Estimated reductions in opioid overdose deaths with sustainment of public health interventions in 4 US states. JAMA Netw Open. 2023;6(6):e2314925–e2314925.

Article  PubMed  PubMed Central  Google Scholar 

Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357.

Parmar MKB, Strang J, Choo L, Meade AM, Bird SM. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths. Addiction. 2017;112(3):502–15.

Article  PubMed  Google Scholar 

Walley AY, Lodi S, Li Y, et al. Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis. Addiction. 2020;115(8):1496–508.

Article  PubMed  PubMed Central  Google Scholar 

Rafful C, Orozco R, Rangel G, et al. Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction. Jun2018;113(6):1056–63.

Article  PubMed  PubMed Central  Google Scholar 

Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. Feb 5 2020;3(2):e1920622.

Fine DR, Lewis E, Weinstock K, Wright J, Gaeta JM, Baggett TP. Office-based addiction treatment retention and mortality among people experiencing homelessness. JAMA Netw Open. 2021;4(3):e210477–e210477.

Article  PubMed  PubMed Central  Google Scholar 

Dhanda A, Salsitz EA. The duration dilemma in opioid agonist therapy. J Opioid Manag Jul-Aug. 2021;17(4):353–8.

Article  Google Scholar 

Coughlin LN, Frost MC, Zhang L, Lin LA. Impact of COVID-19 on stimulant use disorder treatment: a national cohort study in the Veterans Health Administration. Drug Alcohol Depend. 2023;252:110965.

Perumalswami PV, Kilpatrick S, Frost MC, et al. The impact of COVID-19 on trends in alcohol use disorder treatment in Veterans Health Administration. Addiction. Jun2023;118(6):1062–71.

Article  PubMed  Google Scholar 

Gill MJ, Krentz HB. Unappreciated epidemiology: the churn effect in a regional HIV care programme. Int J STD AIDS. Aug2009;20(8):540–4.

Article  PubMed  CAS  Google Scholar 

Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Intl J Drug Policy. 2009;20(3):193–201.

Joudrey PJ, Khan MR, Wang EA, et al. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Prac. 2019;14:1–14.

Google Scholar 

Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592–600.

Article  PubMed  PubMed Central  Google Scholar 

Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019;45(1):1–10.

Article  PubMed  PubMed Central  Google Scholar 

Jordan AE, Bachhuber MA, Tuazon E, et al. Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations. Drug Alcohol Depend. 2024;258:111283.

Hoffman KA, Foot C, Levander XA, et al. Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: a mixed methods analysis. J Subst Abuse Treat. Oct2022;141:108801.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Amram O, Amiri S, Panwala V, Lutz R, Joudrey PJ, Socias E. The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era. Am J Drug Alcohol Abuse. 2021;47(6):722–9.

Article  PubMed  Google Scholar 

Smith LR, Mittal ML, Wagner K, Copenhaver MM, Cunningham CO, Earnshaw VA. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS). Addiction. Feb2020;115(2):354–67.

Article  PubMed  Google Scholar 

Volkow ND. Addiction should be treated, not penalized. Neuropsychopharmacology. Nov2021;46(12):2048–50.

Article  PubMed  PubMed Central  Google Scholar 

Askari MS BM, Ko C, Tuazon, E, Mantha S, Harocopos A. Unintentional drug poisoning (overdose) deaths in New York City in 2021. New York City Department of Health and Mental Hygiene: Epi Data Brief. 2023;133.

Weiner Sg MM, Baker OP, Bernson DMPH, Schuur Jd MM. One year mortality of patients treated with naloxone for opioid overdose by emergency medical services. Subst Abus. 2022;43(1):99–103.

Article  PubMed  Google Scholar